Course Information

Release date: April 8, 2026

Expiration date: April 8, 2027

Estimated time to complete activity: 45 minutes

PROVIDER STATEMENT

This activity is provided by Integrity CE, LLC.

DISCLOSURE OF COMMERCIAL SUPPORT

This program is supported by grants from AbbVie Inc. and Ironwood Pharmaceuticals, Inc, and Salix Pharmaceuticals.

PROGRAM OVERVIEW

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder with a significant negative impact on patient quality of life that is commonly managed in primary care. Despite its high prevalence, IBS remains underdiagnosed and undertreated, with affected individuals often experiencing diagnostic delays, inadequate symptom control, and persistent impairments in daily functioning. The absence of reliable biomarkers, heterogeneous pathophysiology, and ongoing reliance on exclusionary diagnostic approaches contribute to shortcomings in care.

Join our expert faculty to review symptom-based diagnostic criteria, appropriate use of testing, current evidence-based treatment options, and practical strategies for individualized care. The program will also address communication approaches to promote shared decision-making and optimize long-term outcomes for patients with IBS.

Learning Objectives

TARGET AUDIENCE

This educational activity has been designed to meet the needs of primary care clinicians and other healthcare professionals who care for patients with IBS.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

Apply Rome IV criteria to achieve earlier diagnosis of IBS
Create a treatment plan that is consistent with current evidence-based guidelines for patients with IBS
Utilize evidence-based communication strategies and shared decision-making to identify patient needs and guide the treatment of IBS

Faculty Information and Disclosures

Darren M. Brenner, MD
Professor of Medicine and Surgery
Department of Medicine
Division of Gastroenterology and Hepatology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity CE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity CE, LLC for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:

Darren M. Brenner, MD

Advisor, Speaker, Consultant: AbbVie, Aradelyx, Ironwood, Salix
Board of Directors: International Foundations for GI Disorders
Consultant: Alnylam, Bayer, BioAmerica, CinPhloro, Dr. Reddy, Gemelli, Laborie, Vibrant
Non-vested Stock Options: Owlstone, SideBy Care

The Integrity CE, LLC planners and managers do not have any financial relationships or relationships to products or devices with ineligible companies.

Accreditation Information

DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. During the period of April 8, 2026 through April 8, 2027, participants must:

Read the learning objectives and faculty disclosures
Complete the pretest
Study the educational activity
Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed posttest with a score of 28% or better and a completed activity evaluation form. A statement of credit will be issued by our system and immediately available to download following your completion of the posttest and evaluation.

ACCREDITATION STATEMENT

Integrity CE, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity CE, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity CE, LLC at (855) 835-4004 or cme@integrityce.com.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity CE, LLC does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimers and Technical Requirements

MEDIA

Internet

PRIVACY POLICY

When you register or participate in an educational activity sponsored by Integrity CE, LLC, you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and… (continued)

MINIMUM SYSTEM REQUIREMENTS

Internet: Stable connection
Operating Systems: Windows 10/macOS 10.14 or later recommended
Web Browser: Latest versions of Google Chrome, Microsoft Edge, or Safari recommended (other modern browsers also supported)
Plug-ins: No plug-ins required

For optimal performance and security, ensure your browser is up to date and avoid using unsupported or outdated versions

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Primary Care-Based Strategies for Improving IBS Care: Focus on Accurate Assessment and Personalized Treatment